326 related articles for article (PubMed ID: 28650678)
1. An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.
Firoozbakht F; Rezaeian I; D'agnillo M; Porter L; Rueda L; Ngom A
J Comput Biol; 2017 Aug; 24(8):756-766. PubMed ID: 28650678
[TBL] [Abstract][Full Text] [Related]
2. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
[TBL] [Abstract][Full Text] [Related]
3. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
4. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
5. Detection of subtype-specific breast cancer surface protein biomarkers via a novel transcriptomics approach.
Mercatelli D; Formaggio F; Caprini M; Holding A; Giorgi FM
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34750607
[TBL] [Abstract][Full Text] [Related]
6. Identification of significantly mutated subnetworks in the breast cancer genome.
Ajwad R; Domaratzki M; Liu Q; Feizi N; Hu P
Sci Rep; 2021 Jan; 11(1):642. PubMed ID: 33436820
[TBL] [Abstract][Full Text] [Related]
7. Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling.
Li D; Xia H; Li ZY; Hua L; Li L
Biomed Res Int; 2015; 2015():746970. PubMed ID: 25961039
[TBL] [Abstract][Full Text] [Related]
8. GLassonet: Identifying Discriminative Gene Sets Among Molecular Subtypes of Breast Cancer.
Liu S; Zhang Y; Shang X
IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(3):1905-1916. PubMed ID: 36346852
[TBL] [Abstract][Full Text] [Related]
9. A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes.
Dutta B; Pusztai L; Qi Y; André F; Lazar V; Bianchini G; Ueno N; Agarwal R; Wang B; Shiang CY; Hortobagyi GN; Mills GB; Symmans WF; Balázsi G
Br J Cancer; 2012 Mar; 106(6):1107-16. PubMed ID: 22343619
[TBL] [Abstract][Full Text] [Related]
10. Screening of Prognostic Factors in Early-Onset Breast Cancer.
Yu Z; He Q; Xu G
Technol Cancer Res Treat; 2020; 19():1533033819893670. PubMed ID: 32028860
[TBL] [Abstract][Full Text] [Related]
11. Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
Sherafatian M
Gene; 2018 Nov; 677():111-118. PubMed ID: 30055304
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin superfamily genes are novel prognostic biomarkers for breast cancer.
Li Y; Guo M; Fu Z; Wang P; Zhang Y; Gao Y; Yue M; Ning S; Li D
Oncotarget; 2017 Jan; 8(2):2444-2456. PubMed ID: 27911271
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of somatic mutations and transcriptomic data to functionally stratify breast cancer patients.
Zhang J; Abrams Z; Parvin JD; Huang K
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):513. PubMed ID: 27556157
[TBL] [Abstract][Full Text] [Related]
14. Identification of hub subnetwork based on topological features of genes in breast cancer.
Zhuang DY; Jiang L; He QQ; Zhou P; Yue T
Int J Mol Med; 2015 Mar; 35(3):664-74. PubMed ID: 25573623
[TBL] [Abstract][Full Text] [Related]
15. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
[TBL] [Abstract][Full Text] [Related]
16. Protein interaction network (PIN)-based breast cancer subsystem identification and activation measurement for prognostic modeling.
Lim S; Park Y; Hur B; Kim M; Han W; Kim S
Methods; 2016 Nov; 110():81-89. PubMed ID: 27329435
[TBL] [Abstract][Full Text] [Related]
17. Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach.
Zhang D; Chen P; Zheng CH; Xia J
Oncotarget; 2016 Jan; 7(4):4298-309. PubMed ID: 26735889
[TBL] [Abstract][Full Text] [Related]
18. Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.
Karthik GM; Rantalainen M; Stålhammar G; Lövrot J; Ullah I; Alkodsi A; Ma R; Wedlund L; Lindberg J; Frisell J; Bergh J; Hartman J
BMC Cancer; 2017 Nov; 17(1):802. PubMed ID: 29187174
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of Cancer Gene Profiling Data.
Roy J; Winter C; Schroeder M
Methods Mol Biol; 2016; 1381():211-22. PubMed ID: 26667463
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
Li Y; Sahni N; Yi S
Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]